Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Total Current Liabilities (2019 - 2025)

Historic Total Current Liabilities for IM Cannabis (IMCC) over the last 7 years, with Q3 2025 value amounting to $27.9 million.

  • IM Cannabis' Total Current Liabilities fell 289.23% to $27.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.9 million, marking a year-over-year decrease of 289.23%. This contributed to the annual value of $25.5 million for FY2024, which is 476.39% up from last year.
  • As of Q3 2025, IM Cannabis' Total Current Liabilities stood at $27.9 million, which was down 289.23% from $25.4 million recorded in Q2 2025.
  • IM Cannabis' Total Current Liabilities' 5-year high stood at $53.1 million during Q3 2022, with a 5-year trough of $19.3 million in Q1 2023.
  • Over the past 5 years, IM Cannabis' median Total Current Liabilities value was $25.0 million (recorded in 2024), while the average stood at $28.3 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 36542.66% in 2021, then plummeted by 6065.57% in 2023.
  • IM Cannabis' Total Current Liabilities (Quarter) stood at $22.4 million in 2021, then grew by 11.32% to $24.9 million in 2022, then fell by 3.16% to $24.1 million in 2023, then rose by 3.6% to $25.0 million in 2024, then grew by 11.77% to $27.9 million in 2025.
  • Its Total Current Liabilities stands at $27.9 million for Q3 2025, versus $25.4 million for Q2 2025 and $28.4 million for Q1 2025.